Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-09-27 Purchase | 2024-10-01 5:54 pm | Wave Life Sciences Ltd. | WVE | GSK plc 10% Owner | 2,791,930 | $8 | $22,335,440 | 16,775,691 (Indirect) | View |
| 2023-12-07 Purchase | 2024-01-30 4:39 pm | Wave Life Sciences Ltd. | WVE | GSK plc 10% Owner | 3,300,000 | $5 | $16,500,000 | 13,983,761 (Indirect) | View |
| 2021-07-02 Purchase | 2021-07-06 4:38 pm | CVRx Inc. | CVRX | GLAXOSMITHKLINE PLC 10% Owner | 275,000 | $18 | $4,950,000 | 1,007,583 (Indirect) | View |
| 2021-05-20 Sale | 2021-05-24 5:04 pm | Innoviva Inc. | INVA | GLAXOSMITHKLINE PLC 10% Owner | 32,005,260 | $12.25 | $392,064,435 | 0 (Indirect) | View |
| 2021-02-17 Purchase | 2021-02-19 4:50 pm | Decibel Therapeutics Inc. | DBTX | GLAXOSMITHKLINE PLC Director | 150,000 | $18 | $2,700,000 | 1,183,663 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2023-01-30 4:34 pm | N/A N/A | Wave Life Sciences Ltd. | WVE | GSK PLC 10% Owner | 0 | $0 | 10,683,761 (Indirect) | View |
Ownership | 2022-11-14 5:05 pm | N/A N/A | Spero Therapeutics Inc. | SPRO | GSK PLC 10% Owner | 0 | $0 | 9,190,606 (Indirect) | View |
Ownership | 2022-11-04 4:11 pm | N/A N/A | 23andMe Holding Co. | ME | GSK PLC 10% Owner | 0 | $0 | 39,660,487 (Indirect) | View |
| 2022-09-16 Other | 2022-09-20 4:16 pm | N/A N/A | Theravance Biopharma Inc. | TBPH | GSK PLC Former 10% Owner | 269,061,000 | $0 | 9,644,807 (Indirect) | View |
| 2022-09-16 Other | 2022-09-20 4:16 pm | N/A N/A | Theravance Biopharma Inc. | TBPH | GSK PLC Former 10% Owner | 9,644,807 | $9.75 | 9,644,807 (Indirect) | View |
| 2021-07-02 Conversion | 2021-07-06 4:38 pm | N/A N/A | CVRx Inc. | CVRX | GLAXOSMITHKLINE PLC 10% Owner | 13,331,791 | $0 | 1,007,583 (Indirect) | View |
Ownership | 2021-07-06 4:22 pm | N/A N/A | CVRx Inc. | CVRX | GLAXOSMITHKLINE PLC 10% Owner | 0 | $0 | 700,772 (Indirect) | View |
| 2021-06-21 Conversion | 2021-06-23 6:14 pm | N/A N/A | Lyell Immunopharma Inc. | LYEL | GLAXOSMITHKLINE PLC 10% Owner | 30,253,189 | $0 | 30,253,189 (Indirect) | View |
Ownership | 2021-06-17 5:56 pm | N/A N/A | Lyell Immunopharma Inc. | LYEL | GLAXOSMITHKLINE PLC 10% Owner | 0 | $0 | 30,253,189 (Indirect) | View |
| 2021-02-17 Conversion | 2021-02-19 4:50 pm | N/A N/A | Decibel Therapeutics Inc. | DBTX | GLAXOSMITHKLINE PLC Director | 13,016,132 | $0 | 1,183,663 (Indirect) | View |
Ownership | 2021-02-11 9:04 pm | N/A N/A | Decibel Therapeutics Inc. | DBTX | GLAXOSMITHKLINE PLC Director 10% Owner | 0 | $0 | 1,033,663 (Indirect) | View |